調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020

放射免疫測定（RIA）の世界市場：放射免疫測定試薬、放射免疫測定キット、放射免疫測定装置

◆タイトル：Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
◆商品コード：MAM-MD-3826
◆調査・発行会社：MarketsandMarkets
◆発行日：2015年10月20日
◆ページ数：115
◆レポート形式：PDF / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,650 ⇒換算￥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥920,950見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

当調査レポートでは、放射免疫測定（RIA）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場環境分析、種類別分析、需要先別分析、用途別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

This report on the global radioimmunoassay market is analysed and segmented on the basis of type, application, end user, and region. It analyzes the competitive developments, such as alliance, joint venture, and merger & acquisition, in the global radioimmunoassay market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.

The technique of radioimmunoassay (RIA) is advanced and sensitive enough to find small molecules in the blood, and is therefore used for research purposes and diagnosis of diseases, such as cancer. This technique is also implemented by organizations and research labs for specific research purposes that use animal or human serum. The new range of immunoassay kits and analyzers provide remedies for autoimmune diseases, such as diabetes. These are widely used in the process of drug discovery and screening in blood banks.

Radioimmunoassay (RIA) is one of the pivotal and traditional methods used for the testing of endocrinological disorders. RIA also has a prominent usage in the field of neurodegenerative disorders. Despite its high precision, robust nature, and impeccable sensitivity, the global radioimmunoassay market has been witnessing a slow growth, in terms of market value and kit volume. This can be attributed to the paradigm shift in the adoption of alternatives, such as ELISA, chemiluminescence assay, immunofluorescence assay, other non-radio techniques, and lack of automation.

Handling of RIA kits and tracers require special license, which in itself constitute to be a complicated process. Stringent regulatory approvals are required to set up laboratories to conduct RIA procedures. Therefore, skilled and expert professionals are required to be hired to perform RIA tests. As a result of this, the global radioimmunoassay market has been witnessing a slow growth rate.

In Europe, many clinical laboratories are adopting measures to remove RIA tests off their shelf; ELISA has been instrumental in taking over the RIA tests. European Greens is significant in the maintenance of environmental responsibility across different regions. The utilization of radioactive substances in RIA procedures poses a threat to environment and human health. Thus, the present scenario has negatively impacted the usage of RIA tests in Europe due to the conscious effort from the European Greens to replace this. Despite the aforementioned dynamics, Europe captures a major market share in the global RIA market. Majority of the RIA manufacturers are based out of Europe, thereby claiming a strong footprint in Europe.

Siemens recently discontinued the production of their RIA kits, which left its customers with the option of seeking replacement products. This event has resulted in an opportunity for other RIA players to achieve growth in the global RIA market. Companies, such as IBL International (A Tecan Company) (U.S.), DIAsource Immunoassays SA (Italy), DRG International, Inc. (U.S.), and MP Biomedicals, LLC (U.S.), can leverage upon this opportunity to enhance their profits.

The global radioimmunoassay market was dominated by Europe in 2014, followed by North America, Asia, and the Rest of the World (RoW). Europe is expected to continue to lead the market in the coming years, followed by North America. Over the years, there has been a significant growth in the utilization of the radioimmunoassay technique in Europe owing to the advancements in medical research, clinical trials, and pharmaceutical industries. Over the next five years, the growth in the Asian Radioimmunoassay (RIA) Market is expected to be centred in China, India, and Japan. The growth in this region is anticipated to be mainly driven by factors, such as the increasing number of tests performed, rising adoption rate of advanced techniques, and rising intrinsic demand from China and India due to their respective large population base. The market in Asia is projected to grow at the highest CAGR of 4.5% during the forecast period from 2015 to 2020.

The global radioimmunoassay market was valued at $345.2 Million in 2014. The European radioimmunoassay (RIA) market contributed the largest share to the global market, and was valued at $121.5 Million in 2014. It is projected to grow at a CAGR of 3.9% during the forecast period from 2015 to 2020. North America was the second-largest market, and the market in this region is expected to be driven by the gradually increasing awareness, investments by government & non-government organizations, and establishment of research centres.

Some of the major players in the radioimmunoassay globally are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), and others.

【レポートの目次】

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders

2 Research Methodology (Page No. – 15)
2.1 Integrated Ecosystem of the Radioimmunoassay Market
2.2 Arriving at the Radioimmunoassay Market Size
2.2.1 Top-Down Approach
2.2.2 Macro Indicator-Based Approach
2.3 Assumptions

3 Executive Summary (Page No. – 20)

4 Market Overview (Page No. – 22)
4.1 Introduction
4.2 Comparison With Immunoassay Market (Parent Market)
4.3 Market Drivers and Inhibitors

5 Radioimmunoassay (RIA) Market, By Type (Page No. – 27)
5.1 Introduction
5.2 Reagents & Kits Market
5.3 Analyzers Market

6 Radioimmunoassay (RIA) Market, By End User (Page No. – 32)
6.1 Introduction
6.2 Hospital
6.3 Pharmaceutical Industry and CRO
6.4 Academics
6.5 Clinical Diagnostic Laboratories

7 Radioimmunoassay (RIA) Market, By Application (Page No. – 39)
7.1 Introduction
7.2 Research
7.3 Clinical Diagnostics

8 Radioimmunoassay Market, By Geography (Page No. – 48)
8.1 Introduction
8.2 Europe
8.2.1 By Type
8.2.2 By Application
8.2.3 By End User
8.2.4 By Country
8.2.4.1 Germany
8.2.4.2 France
8.2.4.3 U.K.
8.2.4.4 Italy
8.2.4.5 Spain
8.3 North America
8.3.1 By Type
8.3.2 By Application
8.3.3 By End User
8.3.4 By Country
8.3.4.1 U.S.
8.3.4.2 Canada
8.3.4.3 Mexico
8.4 Asia
8.4.1 By Type
8.4.2 By Application
8.4.3 By End User
8.4.4 By Country
8.4.4.1 China
8.4.4.2 Japan
8.4.4.3 India
8.4.4.4 Republic of Korea
8.5 Rest of the World (RoW)
8.5.1 By Type
8.5.2 By Application
8.5.3 By End User

9 Competitive Landscape (Page No. – 82)
9.1 Company Share Analysis

10 Company Profiles (Page No. – 85)
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
10.1 Diasorin S.P.A.
10.2 Euro Diagnostica AB
10.3 Merck Millipore Corporation
10.4 Diasource Immunossays S.A
10.5 Stratec Biomedicals AG
10.6 Berthold Technologies Gmbh & Co. Kg
10.7 Izotop
10.8 Beckman Coulter, Inc.
10.9 Cisbio
10.10 MP Biomedicals LLC
10.11 Perkinelmer, Inc.
10.12 IBL International (A Tecan Company)
10.13 DRG International, Inc.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. – 112)
11.1 Customization Options
11.1.1 Product Analysis
11.1.2 Brand/Product Perception Matrix
11.1.3 Porter’s Five Forces Analysis
11.2 Related Reports

List of Tables (75 Tables)

Table 1 Immunoassay Market Size & Radioimmunoassay Market Size, 2014 (USD Million)
Table 2 Radioimmunoassay (RIA) Market: Comparison With Immunoassay Market (Parent Market), 2013–2020 (USD Million)
Table 3 Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 4 Radioimmunoassay (RIA) Market, By End-User , 2013-2020 (USD Million)
Table 5 Radioimmunoassay (RIA) Market, By Application, 2013-2020 (USD Million)
Table 6 Radioimmunoassay Market, By Geography, 2013-2020 (USD Million)
Table 7 Radioimmunoassay (RIA) Market: Drivers and Inhibitors
Table 8 Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 9 Radioimmunoassay (RIA) Reagents & Kits Market, By Geography, 2013–2020 (USD Million)
Table 10 Radioimmunoassay (RIA) Analyzers Market, By Geography, 2013–2020 (USD Million)
Table 11 Radioimmunoassay (RIA) Market, By End-Users, 2013–2020 (USD Million)
Table 12 Radioimmunoassay (RIA) Market in Hospitals, By Geography, 2013–2020 (USD Million)
Table 13 Radioimmunoassay (RIA) Market in Pharmaceutical Industry and CRO, By Geography, 2013–2020 (USD Million)
Table 14 Radioimmunoassay (RIA) Market in Academics, By Geography, 2013–2020 (USD Million)
Table 15 Radioimmunoassay (RIA) Market in Clinical Diagnostic Laboratories, By Geography, 2013–2020 (USD Million)
Table 16 Radioimmunoassay (RIA) Market, By Application, 2013-2020 (USD Million)
Table 17 Radioimmunoassay (RIA) Market in Research, By Geography, 2013-2020 (USD Million)
Table 18 Radioimmunoassay (RIA) Analyzers Market in Research Application, By Geography, 2013-2020 (USD Million)
Table 19 Radioimmunoassay (RIA) Kits & Reagents Market in Research Application, By Geography, 2013-2020 (USD Million)
Table 20 Radioimmunoassay (RIA) Market in Clinical Diagnostics, By Geography, 2013-2020 (USD Million)
Table 21 Radioimmunoassay (RIA) Analyzers Market in Clinical Diagnostics Application, By Geography, 2013-2020 (USD Million)
Table 22 Radioimmunoassay (RIA) Kits & Reagents Market in Clinical Diagnostics Application, By Geography, 2013-2020 (USD Million)
Table 23 Radioimmunoassay (RIA) Market, By Geography, 2013-2020 (USD Million)
Table 24 Europe: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 25 Europe: Market, By Application, 2013-2020 (USD Million)
Table 26 Europe: Radioimmunoassay (RIA) Analyzers Market, By Application, 2013-2020 (USD Million)
Table 27 Europe: Radioimmunoassay (RIA) Reagents & Kits Market, By Application, 2013-2020 (USD Million)
Table 28 Europe: Market, By End User, 2013-2020 (USD Million)
Table 29 Germany: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 30 Germany: Market, By Application, 2013-2020 (USD Million)
Table 31 France: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 32 France: Market, By Application, 2013-2020 (USD Million)
Table 33 U.K. Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 34 U.K. Market, By Application, 2013-2020 (USD Million)
Table 35 Italy Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 36 Italy Radioimmunoassay (RIA) Market, By Application, 2013-2020 (USD Million)
Table 37 Spain Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 38 Spain Market, By Application, 2013-2020 (USD Million)
Table 39 North America: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 40 North America: Market, By Application, 2013-2020 (USD Million)
Table 41 North America: Radioimmunoassay (RIA) Analyzers Market, By Application, 2013-2020 (USD Million)
Table 42 North America: Radioimmunoassay (RIA) Kits & Reagents Market, By Application, 2013-2020 (USD Million)
Table 43 North-America: Market, By End-User, 2013-2020 (USD Million)
Table 44 U.S.: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 45 U.S.: Market, By Application, 2013-2020 (USD Million)
Table 46 Canada: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 47 Canada: Radioimmunoassay (RIA) Market, By Application, 2013-2020 (USD Million)
Table 48 Mexico: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 49 Mexico: Market, By Application, 2013-2020 (USD Million)
Table 50 Asia: Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 51 Asia: Radioimmunoassay Market, By Application, 2013-2020 (USD Million)
Table 52 Asia: Radioimmunoassay (RIA) Analyzers Market, By Application, 2013-2020 (USD Million)
Table 53 Asia: Radioimmunoassay (RIA) Reagents & Kits Market, By Application, 2013-2020 (USD Million)
Table 54 Asia: Radioimmunoassay Market, By End User, 2013-2020 (USD Million)
Table 55 China: Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 56 China: Market, By Application, 2013-2020 (USD Million)
Table 57 Japan: Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 58 Japan: Market, By Application, 2013-2020 (USD Million)
Table 59 India: Market, By Type, 2013-2020 (USD Million)
Table 60 India: Radioimmunoassay Market, By Application, 2013-2020 (USD Million)
Table 61 Republic of Korea: Radioimmunoassay (RIA) Market, By Type, 2013-2020 (USD Million)
Table 62 Republic of Korea: Market, By Application, 2013-2020 (USD Million)
Table 63 RoW: Radioimmunoassay Market, By Type, 2013-2020 (USD Million)
Table 64 RoW: Radioimmunoassay Market, By Application, 2013-2020 (USD Million)
Table 65 RoW: Radioimmunoassay (RIA) Analyzers Market, By Application, 2013-2020 (USD Million)
Table 66 RoW: Radioimmunoassay (RIA) Reagents & Kits Market, By Application, 2013-2020 (USD Million)
Table 67 RoW: Market, By End User, 2013-2020 (USD Million)
Table 68 Radioimmunoassay (RIA) Kits Market: Company Share Analysis, 2014 (%)
Table 69 Radioimmunoassay (RIA) Analyzers Market: Company Share Analysis, 2014 (%)
Table 70 Diasorin S.P.A: Revenue Mix, 2010-2014 (USD Million)
Table 71 Merck Millipore Corporation: Key Financials, 2010-2014 (USD Million)
Table 72 Stratec Biomedical AG: Revenue Mix, 2010-2014 (USD Million)
Table 73 Danaher Corporations: Key Financials, 2011-2014 (USD Million)
Table 74 Perkinelmer, Inc.: Key Financials, 2010-2014 (USD Million)
Table 75 Tecan Trading AG: Key Financials, 2010-2014 (USD Million)

List of Figures (68 Figures)

Figure 1 Market Segmentation & Coverage
Figure 2 Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Macro Indicator-Based Approach
Figure 5 Market Snapshot, 2014 (%)
Figure 6 Comparison With Immunoassay Market (Parent Market), 2013-2020 (USD Million)
Figure 7 Radioimmunoassay (RIA) Type Market, By Type, 2014 & 2020 (USD Million)
Figure 8 Radioimmunoassay (RIA) End User Market, By Geography, 2014 (USD Million)
Figure 9 Radioimmunoassay (RIA) Application Market, By Geography, 2014 (USD Million)
Figure 10 Market, By Type, 2014 & 2020 (USD Million)
Figure 11 Market, Type Comparison With Parent Market, 2013-2020 (USD Million)
Figure 12 Radioimmunoassay (RIA) Reagents & Kits Market, By Geography, 2014 & 2020 (USD Million)
Figure 13 Radioimmunoassay (RIA) Analyzers Market, By Geography, 2014 & 2020 (USD Million)
Figure 14 Market, By End User, 2014 & 2020 (USD Million)
Figure 15 Radioimmunoassay (RIA) Hospitals Market, By Geography, 2014 & 2020 (USD Million)
Figure 16 Radioimmunoassay Market in Pharmaceutical Industry and CRO, By Geography, 2014 & 2020 (USD Million)
Figure 17 Radioimmunoassay Market in Academics, By Geography, 2014 & 2020 (USD Million)
Figure 18 Radioimmunoassay Market in Clinical Diagnostic Laboratories, By Geography, 2014 & 2020 (USD Million)
Figure 19 Radioimmunoassay Market, By Application, 2014 & 2020 (USD Million)
Figure 20 Radioimmunoassay Market in Research, By Geography, 2014 & 2020 (USD Million)
Figure 21 Radioimmunoassay (RIA) Analyzers Market in Research Application, By Geography, 2014 & 2020 (USD Million)
Figure 22 Radioimmunoassay (RIA) Kits & Reagents Market in Research Application, By Geography, 2014 & 2020 (USD Million)
Figure 23 Market in Clinical Diagnostics, By Geography, 2014 & 2020 (USD Million)
Figure 24 Radioimmunoassay (RIA) Analyzers Market in Clinical Diagnostics Application, By Geography, 2014 & 2020 (USD Million)
Figure 25 Radioimmunoassay (RIA) Kits & Reagents Market in Clinical Diagnostics Application, By Geography, 2014 & 2020 (USD Million)
Figure 26 Europe: Radioimmunoassay Market Overview, 2014 & 2020 (%)
Figure 27 Europe: Market, By Type, 2014 & 2020 (USD Million)
Figure 28 Europe: Radioimmunoassay (RIA) Market, By Application, 2014 & 2020 (USD Million)
Figure 29 Europe: Radioimmunoassay Market (RIA), By End User, 2014 & 2020 (USD Million)
Figure 30 Europe: Radioimmunoassay (RIA) Market, By Country, 2014 & 2020 (USD Million)
Figure 31 Germany: Radioimmunoassay (RIA) Market Overview, 2014 & 2020 (%)
Figure 32 France: Radioimmunoassay (RIA) Market Overview, 2014 & 2020 (%)
Figure 33 U.K.: Radioimmunoassay (RIA) Market, Overview, 2014 & 2020 (%)
Figure 34 Italy: Radioimmunoassay (RIA) Market, Overview 2014 & 2020 (%)
Figure 35 Spain: Radioimmunoassay (RIA) Market Overview 2014 & 2020 (%)
Figure 36 North America Radioimmunoassay (RIA) Market Overview, 2014 & 2020 (%)
Figure 37 North America Radioimmunoassay (RIA) Market, By Type, 2014 & 2020 (USD Million)
Figure 38 North America Radioimmunoassay (RIA) Market, By Application, 2014 & 2020 (USD Million)
Figure 39 North America Radioimmunoassay (RIA) Market, By End User, 2014 & 2020 (USD Million)
Figure 40 North America Radioimmunoassay (RIA) Market, By Country, 2014 & 2020, (USD Million)
Figure 41 U.S. Radioimmunoassay (RIA) Market Overview 2014 & 2020 (%)
Figure 42 Canada: RIA Market Overview, 2014 & 2020 (%)
Figure 43 Mexico: RIA Market Overview, 2014 & 2020 (%)
Figure 44 Asia: Radioimmunoassay (RIA) Market Overview, 2014 & 2020 (%)
Figure 45 Asia: RIA Market, By Type, 2014 & 2020 (USD Million)
Figure 46 Asia: Radioimmunoassay Market, By Application, 2014 & 2020 (USD Million)
Figure 47 Asia: Radioimmunoassay Market, By End User, 2014 & 2020 (USD Million)
Figure 48 Asia: Radioimmunoassay Market, By Country, 2014 & 2020 (USD Million)
Figure 49 China: Radioimmunoassay Market Overview, 2014 & 2020 (%)
Figure 50 Japan: Radioimmunoassay Market, Overview 2014 &2020 (%)
Figure 51 India: Radioimmunoassay Market, Overview 2014 & 2020 (%)
Figure 52 Republic of Korea: Radioimmunoassay Market, Overview 2014 & 2020 (%)
Figure 53 RoW: Market Overview, 2014 & 2020 (%)
Figure 54 RoW: Radioimmunoassay Market, By Country, 2014 & 2020 (USD Million)
Figure 55 RoW: Radioimmunoassay Market, By Type, 2014 & 2020 (USD Million)
Figure 56 RoW: Radioimmunoassay Market, By Application, 2014 & 2020 (USD Million)
Figure 57 RoW: Radioimmunoassay Market, By End User, 2014 & 2020 (USD Million)
Figure 58 Radioimmunoassay (RIA) Kits Market: Company Share Analysis, 2014 (%)
Figure 59 Radioimmunoassay (RIA) Analyzers Market: Company Share Analysis, 2014 (%)
Figure 60 Radioimmunoassay Market: Key Players Operating in Application Areas
Figure 61 Coverage of Key Players By Application
Figure 62 Diasorin S.P.A: Revenue Mix 2014(%)
Figure 63 Diasorin S.P.A: Key Financials, 2010-2014 (USD Million)
Figure 64 Merck Millipore Corporation: Key Financials, 2010-2014 (USD Million)
Figure 65 Stratec Biomedical AG: Key Financials, 2010-2014 (USD Million)
Figure 66 Danaher Corporations: Revenue Mix, 2014 (%)
Figure 67 Perkinelmer, Inc.: Revenue Mix, 2014 (%)
Figure 68 Tecan Trading AG: Revenue Mix, 2014 (%)

 


【レポートのキーワード】

放射免疫測定（RIA）、ラジオイムノアッセイ、放射免疫測定法、放射性同位元素、放射免疫測定試薬、放射免疫測定キット、放射免疫測定装置、免疫学的検定法、放射免疫分析

★調査レポート[放射免疫測定（RIA）の世界市場：放射免疫測定試薬、放射免疫測定キット、放射免疫測定装置] ( Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020 / MAM-MD-3826) 販売に関する免責事項
[放射免疫測定（RIA）の世界市場：放射免疫測定試薬、放射免疫測定キット、放射免疫測定装置] ( Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020 / MAM-MD-3826) についてEメールでお問い合わせ
◆関連調査資料◆
  • イムノアッセイの世界市場予測：試薬、キット、分析器、ソフトウェア、サービス
    MAM-MD-4751 / MarketsandMarkets / 2016年11月17日 / 当調査レポートでは、イムノアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス別分析、技術別分析、用途別分析、需要先別分析、イムノアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global immunoassay market consists of various products that are used by hospitals, clinical laboratories, blood banks, research and academic laboratories, and pharmaceutical companies. The market is expected to reach USD 25.45 Billion by 2021 from USD 17.16 Billion in 2016 at a CAGR of 8.2%. This market is segmented based on product & service, technology, application, end user, and region. The major factors driving the growth of this market are rising incidence of chronic diseases, extensive use of immunoassay in oncology, technological advancements, and cost-effectiveness & rapid analysis of immunoassay. However, the low detection limits of immunoassay, implementation of...
  • 体外診断（IVD）の世界市場予測（～2021）：製品別、技術別（イムノアッセイ、臨床化学、分子診断、血液学）、用途別
    MAM-MD-3609 / MarketsandMarkets / 2016年12月2日 / 当調査レポートでは、体外診断（IVD）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、技術別分析、用途別分析、地域別分析、体外診断（IVD）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global in vitro diagnostics market is estimated to reach USD 78.74 Billion by 2021, at a CAGR of 5.5% during the forecast period. The growing acceptance of molecular diagnostics for personalized medicine, increase in prevalence of chronic lifestyle diseases, and rise in demand for point-of-care testing are driving market growth. New range of condition-specific markers and tests with advances in genomics & proteomics and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. However, the rising healthcare costs & lower budgets and inadequate reimbursement are the major restraining factors for this...
  • In Vitro診断（IVD）の世界市場予測（～2023年）：IVD装置、IVD試薬
    MAM-MD-3609 / MarketsandMarkets / 2018年3月27日 / MarketsandMarketsが発行した当調査レポートでは、In Vitro診断（IVD）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、技術別分析、用途別分析、地域別分析、In Vitro診断（IVD）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The in vitro diagnostics market is projected to grow at a CAGR of 5.2%.”The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories. Moreover, the development of condition-specific markers and tests, growing significance of companion...
  • ライフサイエンス分析の世界市場予測（～2021）：種類別（記述的、処方的）、用途別、構成要素別、提供方法別、需要先別
    MAM-HIT-4869 / MarketsandMarkets / 2017年1月20日 / 当調査レポートでは、ライフサイエンス分析の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、航空機種類別分析、接続性別分析、需要先別分析、フィット別分析、ライフサイエンス分析の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The aircraft interface device market is projected to grow from USD 115.9 Million in 2016 to USD 230.8 Million by 2021, at a CAGR of 14.76% during the forecast period. Increase need for situational awareness and increase in demand for real-time analytics are key factors expected to drive the growth of the market. The market has been segmented based on aircraft type, connectivity, fit, end user, and region. Based on aircraft type, the aircraft interface device market has been segmented into narrow body aircraft, wide body aircraft, very large aircraft, regional transport aircraft, business jet aircraft, military rotary wing aircraft,...
  • 集団健康管理（PHM）の世界市場予測（～2021年）
    MAM-HIT-2429 / MarketsandMarkets / 2017年2月28日 / 当調査レポートでは、集団健康管理（PHM）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、構成要素別分析、エンドユーザー別分析、提供方式別分析、地域別分析、集団健康管理（PHM）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The population health management market is projected to reach USD 42.54 Billion by 2021 from USD 13.85 Billion in 2016, at a CAGR of 25.2% in the next five years (2016 to 2021). The implementation of the Affordable Care Act (ACA) in the U.S., government support for the prevention of diseases and adoption of HCIT, rising geriatric population and the subsequent increase in the prevalence of chronic diseases, need for affordable treatment options due to the rising healthcare costs, and advancing IT and big data capabilities are expected to drive the growth of the market in the coming years. The...
  • 静脈穿刺法処置の世界市場予測（～2021年）
    MD5079 / MarketsandMarkets / 2017年3月15日 / 当調査レポートでは、静脈穿刺法処置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、成功率別分析、静脈種類別分析、需要先別分析、地域別分析、静脈穿刺法処置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...Venipuncture is the procedure of collecting blood from veins through venous access. Intravenous cannulation access is the method to get venous access for venipuncture. Distal to the antecubital fossa in deep-arm veins allows most successful cannulation. Moreover, medical condition of the patient and the experience and training of the technician performing the peripheral intravenous (PIV) access increases the success rate of PIV. Alternate approaches to attain cannulation include central venous catheterization (CVC), peripherally inserted central catheters, external jugular IVs, and ultrasound-guided vascular access. Venipuncture needle and syringes market is projected to reach USD 1,044.6 Million by 2021 from USD 790.8...
  • 血液チューブ自動ラベラ及び検体輸送箱の世界市場予測（～2022年）
    MD-6093 / MarketsandMarkets / 2018年3月15日 / MarketsandMarketsが発行した当調査レポートでは、血液チューブ自動ラベラ及び検体輸送箱の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、需要先別分析、地域別分析、血液チューブ自動ラベラ及び検体輸送箱の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The automated blood tube labeler market is expected to reach USD 142.0 Million by 2022 from USD 102.3 Million in 2017, at a CAGR of 6.8% during the forecast period. The scope of the report includes automated tube labeler used to label blood tubes. The specimen transportation box market is expected to reach USD 135.8 Million by 2022 from USD 94.7 Million in 2017, at a CAGR of 7.5% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. Automated blood tube labeler helps eliminate human errors in...
  • 細胞解離の世界市場予測（～2023年）：酵素系（コラゲナーゼ、トリプシン、DNase、エラスターゼ）、非酵素系
    MAM-BT-6129 / MarketsandMarkets / 2018年3月28日 / MarketsandMarketsが発行した当調査レポートでは、細胞解離の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、種類別分析、組織別分析、需要先別分析、細胞解離の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell dissociation market is expected to reach USD 440.5 Million by 2023 from USD 241.2 Million in 2018, at a CAGR of 12.8%. Market growth is primarily driven by the rising R&D investments in the life sciences industry, increasing research on chronic diseases and rising government funding for cancer research. The global cell dissociation market is segmented by product, tissue, type, end user, and region. By product, the cell dissociation market segmented into enzymatic dissociation products, non-enzymatic dissociation products and instruments & accessories. The enzymatic dissociation products segment estimated to account for the largest market of the global...
  • 外科用ドレーン/創部用ドレナージの世界市場予測（～2022年）
    MD-5663 / MarketsandMarkets / 2017年10月23日 / MarketsandMarketsが発行した当調査レポートでは、外科用ドレーン/創部用ドレナージの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、エンドユーザー別分析、地域別分析、外科用ドレーン/創部用ドレナージの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The surgical drains market is expected to reach USD 2.18 Billion by 2022 from USD 1.82 Billion in 2017, growing at a CAGR of 3.7%. The growth of this market is mainly driven by the growing geriatric population, increasing number of surgical procedures, and rising awareness programs globally. This report segments the wound drainage market into product, type, application, end user, and region. Based on product, the market is segmented into accessories and surgical drainage systems. The surgical drainage systems segment is expected grow at the highest CAGR during the forecast period. The high growth in this segment is attributed...
  • クレアチニン測定の世界市場予測（～2023年）：キット、試薬
    BT-6361 / MarketsandMarkets / 2018年6月11日 / MarketsandMarketsが発行した当調査レポートでは、クレアチニン測定の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（キット、試薬）別分析、テスト種類別分析、サンプル別分析、需要先別分析、クレアチニン測定の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 377.2 Million in 2018, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. This report segments the creatinine measurement market on the basis of type, type of sample, end user, product, and region. By type,...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆